A tetrapeptide isolated from hamster embryo with central opiate properties on gastrointestinal motility but not on pain perception.
The effects of centrally administered kentsin (H-Thr-Pro-Arg-Lys-OH) on intestinal motility and on pain perception were investigated in rats chronically equipped with lateral ventricle catheters. Intestinal motility was recorded electromyographically from electrodes placed on the duodeno-jejunum; analgesia was evaluated by the hot-plate and tail-flick tests. Kentsin (4.0 ug/kg), injected intracerebroventricularly (ICV) 2 hours after the beginning of a meal, restores the "fasted" i.e. the migrating myoelectric complex of intestinal motility, while a 5 times higher dose administered subcutaneously was inactive. The ICV effect of kentsin was blocked by previous ICV administration of naloxone (400 ug/kg). In contrast, kentsin administered ICV (40 ug/kg) or SC (200 ug/kg) did not affect significantly (P greater than 0.05) the time latency in the two analgesic tests during 90 minutes after its administration and did not significantly modify the analgesic effects of (D5-Ala2, Met5) enkephalinamide. We conclude that kentsin when centrally administered acts on opiate receptors to alter gastrointestinal motility but without effects on pain perception.
D000818:Animals; D006224:Cricetinae; D004576:Electromyography; D004723:Endorphins / Q000494:pharmacology*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D007421:Intestine, Small / Q000502:physiology; D009842:Oligopeptides / Q000494:pharmacology*; D010146:Pain / Q000503:physiopathology*; D011957:Receptors, Opioid / Q000187:drug effects*
D004723:Endorphins; D009842:Oligopeptides; D011957:Receptors, Opioid; C017147:kentsin